0001596771-15-000070.txt : 20151002 0001596771-15-000070.hdr.sgml : 20151002 20151002140305 ACCESSION NUMBER: 0001596771-15-000070 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151001 FILED AS OF DATE: 20151002 DATE AS OF CHANGE: 20151002 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Diplomat Pharmacy, Inc. CENTRAL INDEX KEY: 0001610092 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] IRS NUMBER: 382063100 STATE OF INCORPORATION: MI FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4100 S. SAGINAW ST. CITY: FLINT STATE: MI ZIP: 48507 BUSINESS PHONE: 888-720-4450 MAIL ADDRESS: STREET 1: 4100 S. SAGINAW ST. CITY: FLINT STATE: MI ZIP: 48507 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kadlec Gary W CENTRAL INDEX KEY: 0001618898 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36677 FILM NUMBER: 151139626 MAIL ADDRESS: STREET 1: 4100 S. SAGINAW STREET CITY: FLINT STATE: MI ZIP: 48507 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2015-10-01 0 0001610092 Diplomat Pharmacy, Inc. DPLO 0001618898 Kadlec Gary W 4100 S. SAGINAW STREET FLINT MI 48507 1 1 0 0 President Common Stock 2015-10-01 4 M 0 30000 4.28 A 30000 D Common Stock 2015-10-01 4 S 0 28300 27.6028 D 1700 D Common Stock 2015-10-01 4 S 0 1700 28.5429 D 0 D Employee Stock Option to Acquire Common Stock 4.28 2015-10-01 4 M 0 30000 0 D 2022-09-01 Common Stock 30000 234658 D The sale was effected pursuant to a 10b5-1 trading plan initially adopted by the reporting person on June 24, 2015. The plan provides for monthly sales of 30,000 shares of common stock at the market price. Shares that are not sold in a particular month will be available for sale in subsequent months under the plan. A maximum of 60,000 shares remain available for sale under the plan, which is set to expire on December 31, 2015. The price represents the weighted average price of the multiple transactions reported on this line. The shares were sold at prices ranging from $27.17 to $28.15 per share. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price. The price represents the weighted average price of the multiple transactions reported on this line. The shares were sold at prices ranging from $28.22 to $28.84 per share. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price. The options were granted on September 1, 2012. The options began to vest in annual increments of 25% of the option grant on the one-year anniversary of the grant date, to be fully vested after four years. 75% of the options originally granted are currently vested and exercisable. Jeffrey H. Kuras, Attorney-in-fact 2015-10-02